All In Biotech

Drug Trial Radar · NCT00235391

Expanded Access of Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload

A Study to Provide Expanded Access of (Exjade®) Deferasirox to Patients With Congenital Disorders of Red Blood Cells and Chronic Iron Overload From Blood Transfusions Who Cannot Adequately be Treated With Other Locally Approved Iron Chelators

Last checked: Nov 20, 2026Latest source record: Jun 7, 2011 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

1,683

Actual

Start

Oct 2005

Primary completion

Oct 2008

Study completion Oct 2008

Sponsor

Lead sponsor
Novartis PharmaceuticalsNovartis (NVS)
Sponsor type
Industry
First posted
Oct 10, 2005

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Non randomized
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, from 2 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is an open-label, non-randomized, multi-center trial designed to provide expanded access of deferasirox to patients with congenital disorders of red blood cells and chronic iron overload from blood transfusions who cannot adequately be treated with locally approved iron chelators.

Conditions

  • Thalassemia
  • Sickle Cell Disease
  • Diamond Blackfan Anemia
  • Myelofibrosis

Interventions

  • DeferasiroxDrug

    125 mg, 250 mg and 500 mg tablets. Dosage was calculated based on participant's body weight. Tablets were dispersed in water, orange or apple juice and taken orally once a day.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety Profile of Deferasirox Based Upon Drug Administration and Reporting of Serious Adverse EventsTime frame: Baseline to end of study (Median exposure time to drug was approximately 30 weeks; Maximum exposure was 104 weeks)

Locations

141 sites in 12 countries. Site status is shown where the registry gives one.

  • Arkansas Children's Hospital, UAMS College of Medicine

    Little Rock, Arkansas

  • Alta Bates Comprehensive Cancer Center

    Berkeley, California

  • Children's Hospital of Orange County

    Orange, California

  • Children's Hospital and Health Center of San Diego

    San Diego, California

  • Stanford University

    Stanford, California

  • Alfred I. Dupong Hospital for Children

    Wilmington, Delaware

  • Osler Medical, Inc.

    Melbourne, Florida

  • Hematalogy Oncology Associates

    Pensacola, Florida

  • Tampa Children's Hospital at St. Joseph's Hospital

    Tampa, Florida

  • James A. Haley Veterans Hospital

    Tampa, Florida

  • Backus Children's Hospital, Memorial Health University Medical Center

    Savannah, Georgia

  • Hematalogy Oncology Clinic

    Baton Rouge, Louisiana

  • Borgess Hospital

    Kalamazoo, Michigan

  • Children's Hospitals and Clinics of Minnesota

    Minneapolis, Minnesota

  • University of Mississippi Medical Center

    Jackson, Mississippi

  • Children's Mercy Hospital

    Kansas City, Missouri

  • The Cancer Institute of New Jersey

    New Brunswick, New Jersey

  • Schneider Children's Hospital

    New Hyde Park, New York

  • PCTI

    Columbus, Ohio

  • The Children's Medical Center of Dayton

    Dayton, Ohio

  • Oregon Health & Science University

    Portland, Oregon

  • Hershey Medical Center

    Hershey, Pennsylvania

  • Children's Hospitals of Pittsburgh

    Pittsburgh, Pennsylvania

  • Texas Children's Hospital

    Houston, Texas

  • Children's Hospital of the Kings Daughters

    Norfolk, Virginia

  • VCU Pediatric Hematology/Oncology

    Richmond, Virginia

  • University of Washington Seattle Cancer Care Alliance

    Seattle, Washington

  • Ziekenhuisnetwerk Antwerpen-AZ Middelheim

    Antwerp, Belgium

  • Centre Hospitalier Notre Dame et Reine

    Charleroi, Belgium

  • CHR de la Citadelle

    Liège, Belgium

  • Centre Hospitalier Chretien-Clinique Saint-Joseph

    Montegnée, Belgium

  • University of Alberta

    Edmonton, Canada

  • CHUM-Hopital-Notre-Dame

    Montreal, Canada

  • MUHC- Montreal Children's Hospital

    Montreal, Canada

  • MUHC- Royal Victoria Hospital

    Montreal, Canada

  • Hopital de l'Enfant-Jesus

    Québec, Canada

  • The Hospital for Sick Children,

    Toronto, Canada

  • Toronto General Hospital-Hemoglobinopathy

    Toronto, Canada

  • Burrard Medical Building

    Vancouver, Canada

  • The Ottawa Hospital-General Campus

    Ottawa, Ontario, Canada

Showing 40 of 141 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.